PepBank has 2 tripeptide-10 citrulline studies with results. Both of them gave tripeptide-10 citrulline, with 14 results, grouped by what the studies measured. In each group, results from studies in people come first. Data as of 2026-10-30.
Searches 14 results and 2 papers. Newer studies from Europe PMC
Identifiers, parent molecule, targets and development stage, from curated data.
Despite its INCI name, tripeptide-10 citrulline contains four residues: lysine, aspartate, isoleucine and citrulline. It differs from tripeptide-10. Decorinyl is a commercial suspension containing this ingredient.
No molecular target is recorded for this peptide.
Residues, differences from the parent, calculated properties and 3D structure. Source values and calculated values are shown separately.
4 amino acids · 2 modifications
Some values cannot be calculated. The sequence has a non-canonical residue (X). Residue tables cover only the 20 standard amino acids.
@pepdb/chem 0.2.0 · EMBOSS pKa set · ExPASy residue masses
No charge curve
The sequence has a non-canonical residue (X). Residue tables cover only the 20 standard amino acids.
4 residues. Each residue counts in one class; F and W count as aromatic.
No 3D structure
No experimental structure (PDB) and no UniProt entry for an AlphaFold model are listed for this peptide. Synthetic peptides often have neither. The sequence view above is the reference.
Draws the structure in your browser with RDKit (about 2.3 MB, loaded once).
SMILES fromPubChem CID 90479646(opens in a new tab)
CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCNC(=O)N)C(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NPeople first in each area, then animals, then lab cells. Counts are exact and come from studies that gave the peptide.
PepBank reads each paper before it shows the results. This search looks in Europe PMC for newer papers that PepBank has not read yet.
Counts are exact and come from studies that gave the peptide.
Studies by year
2 of 2 studies have results (100%), published 2008 to 2017. Top row: every study. Bottom row: studies with results about Tripeptide-10 citrulline, by class. The rows use different scales.
Studies2 in all, 2008 to 2017
Studies with results2 in all, 2008 to 2017
Retracted studies are left out. A study with results in two classes counts in both.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
Registered trials that test the peptide, with phase, status and dates. A dot marks trials with posted results.
0 trials match. Highest phase first. Data from ClinicalTrials.gov.
No trial matches these filters.
Studies on this peptide. Some have results. The others have none yet.
2 studies match. Retracted studies are left out.
Showing 2 of 2 studiesquery qry_7477a9a41f1d965afca2b347
2 studies
In vitro (cell-free) · 2008
Puig et al. 2008International journal of cosmetic sciencecited by 24
PMID 18377618DOI 10.1111/j.1468-2494.2008.00429.xPUB-18377618
Randomized controlled trial · 2017
Raikou et al. 2017Journal of cosmetic dermatologycited by 15
PMID 28150423DOI 10.1111/jocd.12314PUB-28150423
Page 1 of 1
Raikou V · Journal of cosmetic dermatology · 2017
Randomized controlled trial · 28 results
Puig A · International journal of cosmetic science · 2008
In vitro (cell-free) · 4 results
Approval and sport status, and the safety outcomes reported in study results. Laws and labels change, so check the regulator for the current status.
| Jurisdiction | Body | Status | As of | Source |
|---|---|---|---|---|
| US | FDA | FDA GSRS confirms substance identity. A UNII does not establish drug approval. No approved medicinal label was established in this review. | 27 Oct 2026 | precision.fda.gov (opens in a new tab) |
| EU | EMA | No medicinal marketing authorisation was established. The secondary CosIng entry describes a cosmetic ingredient, not a medicinal approval. | 27 Oct 2026 | specialchem.com (opens in a new tab) |
| Sport | WADA | Status unknown The 2026 list does not name tripeptide-10 citrulline or Decorinyl. | 2026 List | wada-ama.org (opens in a new tab) |
| European Union | Note | INCI: TRIPEPTIDE-10 CITRULLINE. CosIng reference 83256. Secondary ingredient dictionaries report this entry. The official page did not return the ingredient detail during this check. An inventory entry is not a medicinal approval. | 27 Oct 2026 | specialchem.com (opens in a new tab) |
| China | Note | Lubrizol labels Decorinyl China Compliant -Formerly CFDA. This supplier statement does not establish medicinal approval or a verified national registration number. | 27 Oct 2026 | lubrizol.com (opens in a new tab) |
Reported effects from study results.
No safety results from studies in people
The doses that these studies used. They are not recommendations.
No dose was reported in the study results.
PepBank is a research reference. Talk to a doctor before you use any peptide.
Data version, change history and code for this peptide.
curl -s https://Evidence summary for Tripeptide-10 citrulline: counts by class, key results with sources, notices, data version.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated
Top outcomes
The 1 outcome groups with the most study results, by evidence class.
Data version 308560. Bar length is the number of results, not the size of an effect.
Evidence matrix
Study results by outcome and evidence class. Arrows show how the measured outcome moved, not whether the change is good.
| Outcome group | Human | Animal | Lab | Computer model | Total |
|---|---|---|---|---|---|
| Skin and hairSkin and wound | Human: 10 results from 1 study: 10 not reported. Strongest design: Randomized controlled trial | No results | Lab: 4 results from 1 study: 1 increase, 1 decrease, 2 not reported. Strongest design: In vitro (cell-free) | No results | 14 |
1 outcome group shown of 1 · 14 study results
Data version 308560. Shade grows with the number of results. Every cell shows the exact count.